NEW YORK (GenomeWeb) – Lebanese pharmaceutical product manufacturer BPI has signed an agreement to distribute IncellDx's portfolio of immune-oncology and oncology diagnostic products in the Middle East and North Africa.
Included in the deal are IncellDx's OncoTect single-cell assay for quantifying PD-L1 on tumor cells and immune cell subtypes; its single-cell assay for HPV E6/E7 mRNA detection in cervical samples; and its IncellPrep single-cell preparation kit for solid tissues including tumors.